Controlled release of sirolimus from a multilayered PLGA stent matrix

Biomaterials

Volumn 27, Issue 32, 2006, Pages 5588-5595

  Wang, Xintong ^a   Venkatraman, Subbu S ^a   Boey, Freddy Y C ^a   Loo, Joachim S C ^a   Tan, Lay Poh ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Controlled release; Degradation control; Diffusion control; Multilayered; PLGA; Sirolimus

Indexed keywords

CONTROLLED RELEASE; DEGRADATION CONTROL; DIFFUSION CONTROL; MULTILAYERED; PLGA; SIROLIMUS;

BIODEGRADATION; METAL ANALYSIS; MULTILAYERS; ORGANIC POLYMERS; POLYESTERS;

BIOFILMS;

MACROGOL; PLASTICIZER; POLYGLACTIN; POLYMER; RAPAMYCIN;

ARTICLE; BILAYER MEMBRANE; BIODEGRADABILITY; COATED PARTICLE; CONTROLLED DRUG RELEASE; DRUG DEGRADATION; DRUG DIFFUSION; DRUG ELUTING STENT; DRUG RELEASE; MATERIAL COATING; PRIORITY JOURNAL; SIMULATION; WATER TRANSPORT;

DELAYED-ACTION PREPARATIONS; DIFFUSION; KINETICS; LACTIC ACID; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; POLYGLYCOLIC ACID; POLYMERS; SIROLIMUS; STENTS;

EID: 33746847099     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.07.016     Document Type: Article

References (27)

1. Marx S.O., and Marks A.R. Bench to bedside: the development of sirolimus and its application to stent restenosis. Circulation 104 (2001) 852-855
2. Schwartz R.S. Animal models of human coronary restenosis. In: Topol E.J. (Ed). Text book of interventional cardiology. 2nd ed (1994), W.B. Saunders, Philadelphia, PA 365-381
3. Dotter C.T. Transluminally placed coilspring endarterial tube grafts: long term patency in canine popliteal artery. Invest Radiol 4 (1969) 329-332
4. Gruentzig A.R., Senning A., and Siegenthaler W.E. Nonoperative dilation of coronary artery stenosis: percutaneous transluminal cardiovascular angioplasty. N Engl J Med 301 (1979) 61-67
5. Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M.F., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and 3-dimensional intravascular ultraound study. Circulation 103 (2001) 192-195
6. Drachman D.E., Edelman E.R., Seifert P., Groothuis A.R., Bornstein D.A., Kamath K.R., et al. Neointimal thickening after stent delivery of paclitaxol: change in composision and arrest of growth over 6 months. J Am Coll Cardiol 36 (2000) 2325-2332
7. Venkatraman S.S., Tan L.P., Joso J.F.D., Boey F., and Wang X.T. Biodegradable stents with elastic memory. Biomaterials 27 (2006) 1573-1578
8. Venkatraman S., Tan L.P., Vinalia T., Mak K.H., and Boey F. Collapse pressures of biodegradable stents. Biomaterials 24 (2003) 2105-2111
9. Loo J.S.C., Ooi C.P., and Boey F. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(l-lactide) (PLLA) by electron beam radiation. Biomaterials 26 (2005) 1359-1367
10. Loo J.S.C., Ooi C.P., and Boey F. Influence of electron beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA). Biomaterials 26 (2005) 3809-3817
11. Loo J.S.C., Ooi C.P., Wee E.S.H., and Boey F. Effect of isothermal annealing on the hydrolytic degradation rate of poly(lactide-co-glycolide) (PLGA). Biomaterials 26 (2005) 2827-2833
12. Loo J.S.C., Ooi C.P., Tan M.L., and Boey F. Isothermal annealing of PLGA and its effect on radiation degradation. Polym Int 54 (2005) 636-643
13. Loo J.S.C., Ooi C.P., and Boey F. Radiation effects on poly(lactide-co-glycolide) (PLGA) and poly(l-lactide) (PLLA). Polym Degrad Stabil 83 (2004) 259-265
14. Tan L.P., Venkatraman S.S., Sung P.F., and Wang X.T. Effects of plasticization on heparin release from biodegradable matrices. Int J Pharm 283 (2004) 89-96
15. Stack R.S., Califf R.M., Phillips H.R., Pryor D.B., Quigley P.J., Bauman R.P., et al. Interventional cardiac catheterization at Duke Medical Center: new interventional technology. Am J Cardiol 62 Suppl F (1988) 3F-24F
16. Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102 (2000) 399-404
17. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
18. Akselband Y., Harding M.W., and Nelson P.A. Sirolimus inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. Transplant Proc 23 (1991) 2833-2836
19. Nair R.V., Huang X., Shorthouse R., Adams B., Brazelton T., Braun-Dullaeus R., et al. Antiproliferative effect of sirolimus on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo. Transplant Proc 29 (1997) 614-615
20. Poon M., Marx S.O., Galo R., Badimon J.J., Taubman M.B., and Marks A.R. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98 (1996) 2277-2283
21. Suzuki T., Kopia G., Hayashi S., Bailey L.R., Llanos G., Wilensky R., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
22. Holmes D.R., Leon M.B., Moses J.W., Popma J.J., Cutlip D., Fitzgerald P.J., et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for cornary restenosis. Circulation 109 (2004) 634-640
23. Fajadet J., Morice M.C., Bode C., Barragan P., Serruys P.W., Wijns W., et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation 111 (2005) 1040-1044
24. Venkatraman S, Boey F. Release patterns in drug-eluting stents: what works best. Am J Drug Delivery, October 2006, to appear.
25. Nelson F.C., Stachel S.J., Eng C.P., and Sehgal S.N. Manipulation of the C(22)-C(27) region of sirolimus stability issues and biological implications. Bioorg Med Chem Lett 9 (1999) 295-300
26. Simamora P., Alvarez J.M., and Yalkowsky S.H. Solubilization of sirolimus. Int J Pharm 213 (2001) 25-29
27. Raghuvanshi R.S., Singh M., and Talwar G.P. Biodegradable delivery system for single step immunization with tetanus toxoid. Int J Pharm 93 (1993) R1-R5